SCHEMBL7726085

SCHEMBL7726085

C=CCOc1ccccc1-c1nc2nc(SC)nnc2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 17/20 0.47
PDE1A P54750 4/20 0.47
PDE1B Q01064 4/20 0.47
PDE1C Q14123 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
PDE2A O00408 1/20 0.47
PDE6D O43924 1/20 0.47
USP2 O75604 1/20 0.47
PDE9A O76083 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
PDE6A P16499 1/20 0.47
PDE6G P18545 1/20 0.47
PDE4A P27815 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7721820 0.85 PDE5A (0.65) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7723452 0.84 PDE5A (0.53) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7723384 0.84 ALPL (0.51) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7722744 0.84 MEN1 (0.59) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7725949 0.83 PDE5A (0.53) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7718072 0.77 PDE5A (0.65) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7726863 0.70 MEN1 (0.64) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL7721526 0.70 PDE5A (0.67) PDE5APDE1APDE1BPDE1CMEN1
SCHEMBL10735983 0.69 PDE5A (0.48) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7721531 0.69 PDE5A (0.69) PDE5APDE1APDE1BPDE1CMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP claimed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP claimed
US-6391885-B1 CONTROLLING APOPTOSIS IN AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2002-05-21 US disclosed
US-6060477-A Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives CELL PATHWAYS, INC. (US) 2000-05-09 US disclosed
EP-0347146-B1 FUSED PYRIMIDINE DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-09-01 EP disclosed
US-5047404-A Fused pyrimidine derivatives bronchodilator agents, antiallergens SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-09-10 US disclosed
EP-0347146-A2 Fused pyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-12-20 EP disclosed